chrisvoncsefalvay/vaers-outcomes huggingface dataset:
projectile vomiting, temp, fussy, parent said eyes rolled back lasting 30 seconds. Approximately 2 hours after vaccinations symptoms appeared. During the episode her skin turned grayish, clicking sounds with tongue. Seizure like activity.
Pt recv vax on 8/12/96; on 11/6/98 pt exp chicken pox
Consumer accidentally received 2 Bivalent Boosters/received the first Bivalent booster on October 2022 and the second one on 15Feb2023; He also tested positive for Covid 19 infection on 15Dec2022; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (He also tested positive for Covid 19 infection on 15Dec2022) and EXTRA DOSE ADMINISTERED (Consumer accidentally received 2 Bivalent Boosters/received the first Bivalent booster on October 2022 and the second one on 15Feb2023) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 041H22A and 060F22A) for COVID-19 prophylaxis.     No Medical History information was reported.   In October 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Feb-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2022, the patient experienced COVID-19 (He also tested positive for Covid 19 infection on 15Dec2022). On 15-Feb-2023, the patient experienced EXTRA DOSE ADMINISTERED (Consumer accidentally received 2 Bivalent Boosters/received the first Bivalent booster on October 2022 and the second one on 15Feb2023). At the time of the report, COVID-19 (He also tested positive for Covid 19 infection on 15Dec2022) and EXTRA DOSE ADMINISTERED (Consumer accidentally received 2 Bivalent Boosters/received the first Bivalent booster on October 2022 and the second one on 15Feb2023) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.     The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  On 11-Feb-2021, patient received the 1st dose of Moderna COVID-19 vaccine, Lot Number: 001B21A. On 08-Apr-2021, patient received the 2nd dose of Moderna COVID-19 vaccine, Lot Number: 030B21A. On 09-Nov-2021, the patient received the 1st Booster Dose of Moderna COVID-19 vaccine, Lot Number: 014F21A. On 02-Apr-2022, the patient received the 2nd Booster Dose of Moderna COVID-19 vaccine, Lot Number: 002M21A.  No treatment medications were reported.   This case was linked to MOD-2023-712465 (Patient Link).
aches & pains day p/vax then arm started to burn @ inj site & got red & swollen;sought MD help on 26APR98 got antihistamine;28APR98 has improved MD told had an allerg rxn to vax;
Pt showed his arm which was red and warm to the touch in a 2inch by 2inch area. Pt stated it started earlier today. He will watch for progression of state
Patient requested flu and covid vaccines. He received both and his wife ( not present) called and said he was not supposed to get a flu shot and that he already had one last week. He received 2 flu shots. She stated he is mixing things up. He had no problems with flu shot he already had
Patient was given vaccine, couple of minutes, then walked to check out desk. While waiting  patient passed out. Patient was monitored for 30 min and released. Patient did not have any other reactions.
Swelling in feet jaw and left hand; Hot flashes; spots on hands and feet; Feels like cant process thoughts; Shortness of breath; Dizziness; Could not lift head or  move; fever temperature 103; shaking like tremors; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking like tremors), PERIPHERAL SWELLING (Swelling in feet jaw and left hand), HOT FLUSH (Hot flashes), SKIN DISCOLOURATION (spots on hands and feet) and THOUGHT BLOCKING (Feels like cant process thoughts) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003E21A and 003E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced TREMOR (shaking like tremors) and PYREXIA (fever temperature 103). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling in feet jaw and left hand), HOT FLUSH (Hot flashes), SKIN DISCOLOURATION (spots on hands and feet), THOUGHT BLOCKING (Feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (Dizziness) and MOBILITY DECREASED (Could not lift head or  move). The patient was treated with ALBUTEROL [SALBUTAMOL] for Breathing difficult, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, TREMOR (shaking like tremors), PERIPHERAL SWELLING (Swelling in feet jaw and left hand), HOT FLUSH (Hot flashes), SKIN DISCOLOURATION (spots on hands and feet), THOUGHT BLOCKING (Feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (Dizziness), MOBILITY DECREASED (Could not lift head or  move) and PYREXIA (fever temperature 103) outcome was unknown.      No concomitant medication were provided by the reporter   This case was linked to MOD-2021-285303 (Patient Link).
PT GIVEN VACCINES, DISCHARGED FROM CLINIC, WALKED OUT TO CAR. MOTHER RAN IN TO STATE PT WAS HAVING A SEIZURE. OFFICE STAFF CALLING EMS WHILE OTHER STAFF MEMBER WENT OUT TO CAR WITH O2 TANK & PULSE OX, PT SITTING IN FRONT PASSENGERS SEAT OF CAR WITH SEATBELT ON. ALERT AND ORIENTED X3, LIPS PALE, O2 SAT 99, PULSE 40 ON INITIAL CHECK. PT STATES UNSURE WHAT HAPPENED, MOTHER STATES PT HAD A SEIZURE, WHEN ASKED WHAT HAPPENED DURNING SEIZURE STATES "SHE HAD A SEIZURE" FATHER IN CAR STATES HER EYES ROLLED TO THE BACK OF HER HEAD. WHEN ASKED IF PT GOT TENSE OR STARTED SHAKING HE STATES YES. PT REMAINS A&OX 3, COLOR TO LIPS RETURNED, HEART RATE RETURNS TO HIGH 60S - LOW 70S. MOTHER STATES DOES NOT WANT TO WAIT FOR EMS TO ARRIVE AS LOCAL ER 0.5MILE DOWN THE ROAD. PT REMAINS A&O. NO URINARY INCONTINENCE OBSERVED. PT TAKEN TO ER VIA PRIVATE VEHICLE PER PARENTS.
Pt requested Hepatitis A/B vaccine. Pt received Tdap. No issues reported.
Not even a minute after receiving my shot, while the RN was about to take my blood pressure, I fainted. I?m not sure how long I was out for, but based on my apple watch (probably not the most reliable tool), my heart dropped 30bpm over the course of a minute, at roughly 8:40am. My heart rate slowly climbed back up to almost normal by about 8:50am. I went from feeling nauseous and very hot & sweaty to going unconscious  in a matter of seconds. I was laid down, while one nurse put a cold wet towel under my neck, one held my legs up, another kept taking my blood pressure, and another went to get me juice/gatorade. Throughout the day I felt more faint than usual when standing up (cautiously) after sitting up. After the day had passed, however and I woke up the morning, I felt much better and still do.
Morning after receiving vaccines awoke with c/o a headache 'in the back of her head' - headache persisted for 2 days, better with TYLENOL/MOTRIN.  No intercurrent illness/injury-trauma.
5x5 cm well-circumscribed erythematous circular area on right mid to upper arm. Approx 3-5 cm below suspected Moderna injection site. Warm, hard, and tender to touch. Brachial pulse +2 bilaterally. No issues with ROM.
chickenpox next day-w/infected blister on foot;dx cellulitis of lt foot presented to MD 8/19/99;
Elevated Blood pressure; vial was shortfilled; Rash on fore arm; A spontaneous report was received from a nurse concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vial was short filled, increased blood pressure, and injection site rash.  The patient's medical history was not provided.  No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 (lot number 012L20A) on 11 Jan 2021 intramuscularly for COVID-19 prophylaxis.  On 11 Jan 2021, the patient was given a dose from a vial that could only produce 7 doses instead of 10 doses.  The patient also experienced a rash on her forearm and had raised blood pressure.  She went to the emergency room. Treatment included loratadine, and she was able to return to the office within 2 hours.    Action taken for the events was not reported.  The events, vial was short filled, increased blood pressure and injection site rash, were considered recovered/resolved on 11 Jan 2021.; Reporter's Comments: This case concerns a female patient, who experienced a Manufacturing issue NEC and serious unexpected event of blood pressure increased and non-serious expected event of injection site rash. There were no reported AEs associated with this case of manufacturing issue NEC. The events of blood pressure increased, injection site rash occurred 1 day (same day) after first dose of mRNA-1273, lot # 012L20A. Treatment included Claritin. Based on the current available information and temporal association between the use of the product and onset of the events (blood pressure increased, injection site rash) a causal relationship cannot be excluded.
Initial report received from a physician on 19 Jun 2007. A 24 year old, female patient developed nausea, vomiting and hives after she received YF-VAX (lot number UF044AA) subcutaneously in the right deltoid on 14 June 2007. The patient did not have any illness and was not on any medications at the time of the vaccination. It was reported the patient recovered. Follow up received from a health care professional; Lot number for YF VAX WAS confirmed (UF044AA). The patient underwent, on an unspecified date, an ultrasound (U/T) that was positive for Urinary Tract Infection (UTI). The patient did not have any relevant medical history and was not ill at vaccination time. The patient did not have adverse events following prior vaccination. Follow-up information received 23 October 2007. The onset date and date of recovery for the urinary tract infection were reported to be unknown. No additional information was provided at the time of the report.
Red, raised, hot to touch. Area around injection site; physician treated with cephalexin to prevent possible cellulitis.
Systemic: Allergic: Rash (specify: facial area, extremities)-Severe, Systemic: Flushed/Sweating-Severe, Additional Details: After receiving the Pfizer vaccines, patient's face broke-out in acne like blemishes. Patient's face is red and inflamed. He went to the dermatologist. They diagnosed him with dermatitis.
The patient states that her right arm (same arm as injection site) had become red around the injection site, and it is also itchy and warm. The patient denies any shortness of breath or hives on anywhere on her body. She states that she feels ok besides the above reaction.
Rash on entire body, swelling on entire body, breathing difficulties and throat is swelling.
being tired and having pain; After 2 weeks she has not been well at all, she has been unwell, she is in so much pain at back of part of her body; being tired and having pain; After 2 weeks she has not been well at all, she has been unwell, she is in so much pain at back of part of her body; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 14Mar2021 (Batch/Lot number: unknown) as dose 2,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose:1, Manufacturer unknown), for Covid-19 immunisation. The following information was reported: PAIN (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "being tired and having pain"; MALAISE (non-serious), BACK PAIN (non-serious), outcome "unknown" and all described as "After 2 weeks she has not been well at all, she has been unwell, she is in so much pain at back of part of her body".  Additional information: Patient received the Pfizer vaccine, the second one, on 14Mar2021 and she had the first reactions of being tired and having pain. After 2 weeks she has not been well at all, she has been unwell, she is in so much pain at back of part of her body. She is wondering what she could do. Does this have to do with the Pfizer COVID vaccine. She saw her doctor and he said that it is probably from the vaccine. She says that there are two types of vaccines, there is one in a tube and one in a syringe and her one came in the syringe.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
22 MO OLD BOY GOT HIS INFLUENZA VACCINE 10/30/06;  HE DEVELOPED FEVER OF 105F AND SEIZURES ON 10/31/06.  HE WAS TAKEN TO LOCAL HOSPITAL VIA AMBULANCE.  LAB WORK AND CT WERE NORMAL AND HE WAS DISCHARGED.  HE FOLLOWED TODAY IN CLINIC AND LOOKS NORMAL WITH A NEGATIVE EXAM AND NO FEVER. 11/7/06 Received medical records from PCP which reveal patient in good health & normal development as of 7/06.  Next vs was for flu fax on 10/30.  Last visit is 11/1 as f/u to ER visit for febrile seizures.  Labs, CT & CXR reported by PCP as WNL but   CT of brain report revealed possible mastoiditis.  Parent refused LP.  Patient was to continue on oral antibiotics./ss  12/1/06 2nd letter faxed to hospital to request medical records/ss 1/9/07 Received medical records from hospital which reveal patient seen in ER on 11/1/06 following seizure activity which included post ictal period in ambulance & ER.  Recent hx of febrile illness with rhinitis & cough.  Temp 103.6 in ER.  Treated with IM antibiotics & given oral antibiotics upon d/c to home FINAL DX:  Seizure; fever; & bronchiolitis.
Received by error Infanrix instead of Tdap; 11 yo patient received by error Infanrix; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10th June 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 2-May-2022 Reporter's comments: Medical Assistant reported that a 11 years and 4 months old patient received Infanrix -Dtap pediatric dose by error instead of a Tdap adult dose. The consent to follow up was given by email. Additional Supportive Information: The patient received Infanrix instead of Tdap, which led to wrong vaccine used and inappropriate age at vaccine administration.
MOTHER STATED, "PT HAD 2 SEIZURES THE NIGHT SHE RECEIVED TD SHOT."
This spontaneous report was received from a healthcare worker refers to a 11 year old male patient with VIGAMOX allergy and none pertinent medical history. On 25-MAR-2013 the patient was vaccinated with the first dose of GARDASIL (lot # H010649 and exp date 20-FEB-2013) 1 vial, intramuscular (dose, not reported). No other co suspects were reported. No concomitant therapy was reported. The healthcare worker reported that on 02-APR-2013, the patient developed headache, dizziness, body aches and body weakness after receiving the first dose of GARDASIL. The patient sought medical attention, the patient saw the physician. Treatment was not given. CBC and UA were performed. The outcome of the patient developed headaches, the patient developed body weakness, the patient developed body aches and the patient developed dizziness was reported as recovering/resolving. Additional information has been requested.
c/o "heavy tongue", scratchy throat, able to communicate without difficulty . 0.5ml Epinephrine given SQ sx's resolved. Public Health Medical director notified.
On 03/06/2023, I began to have a dry cough, accompanied with fatigue. I went to a local clinic where I was tested for COVID-19 and flu and a few other things, which were negative. I didn't have a fever or sore throat and my lungs are clear. I don't have congestion or mucus. I'm feeling a lot better now, but I still have a lingering dry cough. The doctor couldn't diagnose me with anything for sure and did not prescribe anything. I've been treating myself with an over-the-counter cough medicine.
Fairly severe nausea ? lasted about 8 days.   Constantly felt like I was going to vomit, although I never did.
pt recv vax 10JUL95 & pt exp a mild, 2x4 inch erythematous area on inner aspect of the forearm;pt recovered by 14JUL95;
Mild nausea; Mild fatigue; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via unspecified route of administration at left arm on 14Jan2021 at 08:00 AM at single dose for COVID-19 immunization. Medical history was not provided. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included simvastatin (within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2. The patient experienced mild nausea and mild fatigue 6 hours after injection, at 02:00 PM on 14Jan2021. Duration for one week (6 days 10 hours). The events were reported as non-serious. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive treatment for the adverse events. Outcome of the events was recovered on 21Jan2021.
I'm a nursing mother and noticed the decrease of milk production went down by 50% since my vaccination.
The patient presented to our clinic with left calf pain and swelling, shortness of breath without chest pain, low grade fever. He was slightly tachycardic with elevated blood pressures to 160s/90s but had O2 saturation of 99%. DVT US showed extensive thromboembolism of left superficial femoral vein down to popliteal vein and  calf veins. CTA chest showed bilateral sub-segmental PE. He was transferred to the the ED for PE workup and treatment.
part of the dose went down the patients arm and they did not get the complete dosage; the syringe leaked or was an issue with Huber Lok/ syringe multifunctioned; part of the dose went down the patients arm and they did not get the complete dosage; Initial information received on 23-Apr-2019 regarding an unsolicited valid non-serious case received from a nurse by phone.  This case involves a 35 years old female patient who was vaccinated with 0.5 ml dose of TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI] (Batch number: NG10 and expiry date: 30-Jun-2019) via intramuscular route in the right deltoid.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A VACCINE) and DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (DIPHTHERIA AND TETANUS TOXOIDS) on an unknown date.  It was a case of actual medication error due to vaccine underdose. and Exposure via skin contact  It was also a case of syringe issue.  It was reported that usually pulls off the cap to put needle on but she is not sure why it is designed this way. It is sealed baggage and she was not sure why the rubber tip is there and said this was not normal course for nurses. She said it took her a while to figure this syringe out but now she know. But the person who did this injection may not have known. She said she is not sure what is the purpose of that rubber cap, if any. Caller said this poor woman has a lot of things going wrong for her.  It was unknown if any adverse event occurred or not following the vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.   Documents held by the sender: none.
Patient was given Td vaccination instead of the tdap vaccination. No side effects or complications occurred from vaccination. Patient tolerated vaccination well however wrong vaccine given. Notified CPC, clinic manager, and local health department for guidance. Spoke with patient on 07/27/2021 with further instruction.
Patient started to experience AE shortly after; sore, difficulty moving LA.  Referred to PT
Approximately 14 hours after receiving mandatory flu vaccine, which was given very high in right shoulder, I experienced pain in shoulder joint with movement. This worsened significantly over next 2 weeks. I was seen by employee health physician, who ordered an MRI, and then referred me to an orthopedic surgeon, based on those results. NSAIDS, pain medications, and physical therapy were prescribed. Mild improvement has occurred; physical therapy is on-going.